Retatrutide activates GIP, GLP-1, and glucagon receptors three distinct receptors, not a third-generation GLP-1
In analyses of people with pre-existing SUDs, GLP-1 receptor agonist use (versus SGLT-2 inhibitor use) was associated with a reduced risk of subsequent adverse clinical events, including SUD related emergency department visits, hospital admissions, and mortality, drug overdose, and suicidal ideation or attempt
A velvety-rich moisturizer to deeply nourish and restore the feel of elasticity
When we combine these two, we move from treating dysfunction to rebuilding intelligence
Each step helps determine whether dose calibration is occurring on a stable metabolic foundation